Treatment of cocaine-dependence;Die behandlung der kokainabhangigkeit

Fortschritte der Neurologie Psychiatrie

Volumn 68, Issue 5, 2000, Pages 224-238

  Preuß, Ulrich W ^a   Bahlmann, M ^a   Koller, G ^a   Soyka, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR THERAPY; COCAINE DEPENDENCE; DETOXIFICATION; GERMANY; HUMAN; PSYCHOANALYSIS; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME; INTOXICATION; RECURRENT DISEASE; REVIEW;

COCAINE;

COCAINE; COCAINE-RELATED DISORDERS; HUMANS; OVERDOSE; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0342424280     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-11634     Document Type: Article

References (134)

1. Peterson R. Rauschgiftlage 1995. In: Deutsche Hauptstelle gegen Suchtgefahren (Hrsg.). Jahrbuch Sucht '97. Geesthacht: Neuland Verlag, 1996: 55-72
2. Halikas JA, Crosby RD, Pearson VL, Graves NM. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. Clinical Pharmacology and Therapeutics 1997; 62 (1): 89-105
3. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46: 117-121
4. Means LB, Small M, Capone DM, Capone TJ, Condren R, Peterson M, Hayward B. Client demographics and outcome in outpatient cocaine treatment. Int J Addict 1989; 24 (8): 765-783
5. Higgins ST, Delaney DD, Budney AJ, Bickel WK, Hughes JR, Foerg F, Fenwick JW. A behavioral approach to achieving initial cocaine abstinence. Am-J-Psychiatry 1991; 148 (9): 1218-1242
6. Carroll KM, Ziedonis D, O'Malley S, McCance-Katz EF, Gordon L, Rounsaville B. Pharmacologic interventions for abusers of alcohol and cocaine: a pilot study of disulfiram versus naltrexone. J Drug Addiction 1993; 2: 77-79
7. Soyka M. Drogen und Medikamentenabhängigkeit. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH, 1998: 61-71
8. Killy JE, Lorang D, Amara SG. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 1991; 254: 576-578
9. Woolverton WL, Johnson KM. Neurobiology of cocaine abuse. TIPS 1992; 13: 192-200
10. Voss HL. Patterns of drug use. Data from the 1985 National Household Survey. NIDA-Research-Monograph-Series 1989; 91: 33-46
11. Anthony JC, Petronis KR. Epidemiologic evidence on suspected associations between cocaine and psychiatric disturbances. In: Schober S, Schade C (eds.). The Epidemiology of Cocaine Use and Abuse. National Institute on Drug Abuse Research Monograph 110. Washington DC: DHHS Pub No (ADM); Supt of Docs, US Govt Print Off, 1991: 91-1787; 71-94
12. Wagner-Echeagaray FA, Schutz CG, Chilcoat HD, Anthony JC. Degree of acculturation and the risk of crack cocaine smoking among Hispanic Americans. Am J Public Health 1994; 84/11: 1825-1827
13. Kleber HD. Pharmacotherapy, current and potential for the treatment of cocaine dependence. Clinical Neuropharmacology 1995; 18 (Suppl 1): 96-106
14. Van-Etten ML, Anthony JC. Comparative epidemiology of initial drug opportunities and transitions to first use. Marijuana, cocaine, hallucinogens and heroin. Drug Alcohol Dependence 1999; 54/2: 117-125
15. Schweer T, Strasser H. Die Straßendroge Crack: Eine erste Bestandsaufnahme. Sucht 1994; 40 (2): 121-126
16. Perkonigg A, Beloch E, Garzynski E, Nelson CB, Pfister H, Wittchen HU. Prävalenz von Drogenmissbrauch und -abhängigkeit bei Jugendlichen und jungen Erwachsenen. Gebrauch, Diagnosen und Auftreten erster Missbrauchs- und Abhängigkeitsmerkmale. Z Klin Psychologie 1997; 26 (4): 247-257
17. Bührs R. Drogen - Entwicklungen - Trends. Analyse empirischer Daten von 781 suchtmittelabhängigen Jugendlichen und jungen Erwachsenen. Sucht 1993; 39: 35-44
18. Simon R, Wibilishauser PM. Ergebnisse der Repräsentativerhebung 1990 zum Konsum und Missbrauch von illegalen Drogen, alkoholischen Getränken, Medikamenten und Tabakwaren. Sucht 1993; 39: 177-180
19. Kraus L, Schumann J, Wiblishauser PU, Herbst K. Die Entwicklung des Konsums von legalen und illegalen Drogen in den neuen Bundesländern. Sucht 1994; 40 (2): 107-120
20. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnoses in cocaine abusers. Arch Gen Psychiatry 1986; 43: 107-113
21. Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 1991; 148: 1712-1716
22. Jacobs IG, Roszler MH, Kelly JK, Klein MA, Kling GA. Cocaine abuse: neurovascular complications. Radiology 1989; 170: 223-227
23. Chow JM, Menchen SL, Paul BD, Stein RJ. Vascular changes in the nasal submucosa of chronic cocaine addicts. Am J Forensic Med Pathol 1990; 11: 136-143
24. Rubin RB, Neugarten J. Cocaine rhabdomyolysis masquerading as myocardial ischemis. Am J Med 1989; 86: 551-553
25. Freye E. Maßnahmen bei der Akutintoxikation mit Kokain und Amphetaminabkömmlingen. Klinikarzt 1997; 4: 101-107
26. Julien RM. Drogen und Psychopharmaka. Heidelberg, Berlin, Oxford: Spektrum Akademischer Verlag, 1996: 133-164
27. Caine SB, Koob GF. Modulation of cocaine self-administrations in the rat through D-3 dopamine receptors. Science 1993; 260: 1814-1816
28. Gawin FH. Neuroleptic reduction of cocaine-induced paranoia but not euphoria? Psychopharmacology (Berl) 1986; 90: 142-143
29. Kuhar MJ, Pilotte NS. Neurochemical changes in cocaine withdrawal. Trends Pharmacol Sci 1996; 17 (7): 260-263
30. Leukefeld CG, Tims FM. Relapse and recovery in drug abuse. Int J Addict 1989; 24 (3): 189-201
31. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46: 117-121
32. Gawin FH, Kleber HD. Cocaine abuse treatment with lithium and desipramine. Arch Gen Psychiatry 1984; 41: 903-909
33. Giannini AJ, Malone DA, Giannini MC, Price WA, Loiselle FH. Treatment of depression in chronic cocaine and phenylcyclidine abuse with desipramine. J Clin Pharmacol 1986; 26: 211-214
34. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Arch Gen Psychiatry 1994; 51: 989-997
35. Tennant FS, Tarver AL. Double-blind comparison of desipramine and placebo in withdrawal from cocaine dependence. NIDA Res Monogr 1984; 55 (1): 159-163
36. Kosten TR, Morgan CM, Falcione J, Schottenfeld RS. Pharmacotherapy for cocaine abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry 1992; 49: 894-898
37. Weddington Jr WW, Brown BS, Haertzen CA, Hess JM, Makaffey JR, Kolar AF, Jaffe JH. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am J Drug Alcohol Abuse 1991; 17: 137-152
38. Gößling HW, Sjnkel S, Wegener U, Woiton V. Auswirkungen fraktionierter Methadongabe im klinischen Opiatentzug. Fortschr Neurol Psychiat 1998; 6: 278-285
39. Waldvogel D, Uehlinger C. Zur Häufigkeit der Injektion von Methadon-Trinklösungen an einem Behandlungszentrum für Opiatabhängige. Fortschr Neurol Psychiat 1999; 67: 281-283
40. Arndt IO, Dorozynsky L, Woody GE, McLellan AT, O'Brien CP. Desipramine treatment of cocaine dependence in methadone-maintained patients. Arch Gen Psychiatry 1992; 49 (11): 888-893
41. Arndt IO, McLellan AT, Dorozynsky L, Woody GE, O'Brien CP. Desipramine treatment for cocaine dependence. Role of antisocial personality disorder. J Nerv Ment Dis 1994; 182 (3): 151-156
42. Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Dependence 1994; 35: 31-35
43. Levin FR, Lehman AF. Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction. J Clin Psychopharm 1991; 11: 374-378
44. Ziedonis D, Richardson T, Lee E, Petrakis I, Kosten T. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics. Psychopharm Bulletin 1992; 28 (3): 309-314
45. Nunes EV, McGrath PJ, Quitkin FM, Ocepek Welikson K, Stewart JW, Koenig T, Wager S, Klein DF. Imipramine treatment of cocaine abuse: possible boundaries of efficacy. Drug Alcohol Depend 1995; 39 (3): 185-195
46. Nunes EV, Quitkin FM, Donovan SJ, Deliyannides D, Ocepek Welikson K, Koenig T, Brady R, McGrath PJ, Woody G. Imipramine treatment of opiate-dependent patients with depressive disorders - A placebo-controlled trial. Arch Gen Psychiatry 1998; 55 (2): 153-160
47. Galloway GP, Newmeyer J, Knapp T, Stalcup SA, Smith D. Imipramine for the treatment of cocaine and methamphetamine dependence. J Addict Dis 1994; 13 (4): 201-216
48. Brotman AW, Witkie SM, Gelenberg AJ, Falk WE, Wojcik J, Leahy L. An open trial of maprotiline for the treatment of cocaine abuse: a pilot study. J Clin Psychopharmacol 1988; 8: 125-127
49. Gold MS, Dackis CA. New insights and treatments: opiate withdrawal and cocaine addiction. Clin Ther 1984; 7: 6-21
50. Gawin FH, Allen D, Humblestone B. Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate: a preliminary report. Arch Gen Psychiatry 1989; 46 (4): 322-325
51. Kampman K, Volpicelli JR, Alterman A, Cornish J, Weinrieb R, Epperson L, Sparkman T, O'Brien CP. Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial. Drug and Alcohol Dependence 1996; 41: 25-33
52. Tennant Jr FS, Sagherian AA. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Intern Med 1987; 147 (1): 109-112
53. Sitland-Marken PA, Well BG, Froemming JH, Chung Chou C, Brown CS. Psychiatric applications of bromocriptine therapy. J Clin Psychiatry 1990; 51 (2): 68-82
54. Dackis CA, Gold MS. Bromocriptine as treatment of cocaine abuse. Lancet 1985; 1 (8438): 1151-1152
55. Dackis CA, Gold MS, Sweeney DR, Byron Jr JP, Climko R. Single-dose bromocriptine reverses cocaine craving. Psychiatry Res 1987; 20 (4): 261-264
56. Gutierrez-Esteinou R, Baldessarini RJ, Cremens MC, Campbell A, Teicher MH. Interactions of bromocriptine with cocaine. Am J Psychiatry 1988; 145 (9): 1173
57. Campbell A, Baldessarini RJ, Cremens C, Teicher MH, Marsh E, Kula NS. Bromocriptine antagonizes behavioral effects of cocaine in the rat. Neuropsychopharmacology 1989; 2 (3): 209-224
58. Kranzler HR, Bauer LO, Hersh D, Klinghoffer V. Carbamazepine treatment of cocaine dependence: a placebo-controlled trial. Drug Alcohol Dependence 1995; 38: 203-211
59. Jaffe JH, Cascella NG, Kumor KM, Sherer MA. Cocaine-induced cocaine craving. Psychopharmacology 1989; 97: 59-64
60. Giannini AJ, Baumgartel P, DiMarzio LR. Bromocriptine therapy in cocaine withdrawal. J-Clin-Pharmacol 1987; 27 (4): 267-270
61. Giannini AJ, Folts DJ, FeatherJN, Sullivan BS. Bromocriptine and amantadine in cocaine detoxification. Psychiatry Res 1989; 29 (1): 11-16
62. Handelsman L, Rosenblum A, Palij M, Magura S, Foote J, Lovejoy M, Stimmel B. Romocriptine for cocaine dependence. A controlled clinical trial. Am J Addict 1997; 6 (1): 54-64
63. Eiler K, Schaefer MR, Salstrom D, Lowery R. Double-blind comparison of bromocriptine and placebo on cocaine withdrawal. Am J Drug Alcohol Abuse 1995; 21 (1): 65-79
64. Alterman AI, Droba M, Antelo RE, Cornish JW, Sweeney KK, Parikh GA, O'Brien CP. Amantadine may facilitate detoxification of cocaine addicts. Drug and Alcohol Dependence 1992; 31 (1): 19-29
65. Berger P, Gawin F, Kosten TR. Treatment of cocaine abuse with mazindol. Lancet 1 1989; (8632): 283
66. Margolin A, Avants SK, Kosten T. Mazindol for relapse prevention to cocaine abuse in methadone maintained patients. Am J Drug Alcohol Abuse 1995; 21 (4): 469-481
67. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K, Carr K, Hall S. Haloperidol antagonism of cue-elicited cocaine craving. Lancet 1996; 347: 504-508
68. Smelson DA, Roy A, Roy M. Risperidone and neuropsychological test performance in cocaine-withdrawn patients (letter). Can J Psychiatry 1997; 42 (4): 431
69. Khantzian EJ. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. Am J Psychiatry 1983; 140: 784-785
70. Khantzian EJ, Gawin FH, Riodan C, Kleber HD. Methylphenidate treatment of cocaine dependence: a preliminary report. J Subst Abuse Treat 1984; 1: 107-112
71. Levin F, Kleber H. Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Hav Rev Psychiatry 1995; 2: 246-255
72. Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence of concurrent opiat and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharmacology 1995; 15 (3): 163-174
73. Gawin FH, Riordan C, Kleber H. Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse 1985; 11: 193-197
74. Wolfsohn R, Sanfilipo M, Angrist B. A placebo-controlled trial of L-DOPA/Carbidopa in early cocaine abstinence. Neuropsychopharmacology 1993; 9: 49-53
75. Heßlinger B, Klose P, Normann C, Langosch JM, Berger M, Walden J. Zur adjuvanten Behandlung schizophrener Störungen mit Carbamazepin. Fortschr Neurol Psychiat 1998; 66: 145-150
76. Halikas JA, Kuhn KL. A possible neurophysiological basis of cocaine craving. Ann Clin Psychiatry 1990; 2: 79-83
77. Halikas JA, Kemp K, Kuhn K, Carlson GA, Crea F. Carbamazepine for cocaine addiction? (letter). Lancet 1989; 1: 623-624
78. Halikas JA, Crosby RD, Carlson GA, Gravea F, Graves NM, Bowers LD. Cocain reduction in unmotivated crack users using carbamazepine versus placebo in a short term, souble blind cross-over design. Clin Pharmacol Ther 1991; 50: 81-95
79. Kranzler HR, Bauer LO. Bromocriptine and cocaine cue reactivity in cocaine-dependent patients. Br J Addiction 1992; 87: 1537-1548
80. Montoya ID, Levin FR, Fudala PJ, Gorelick DA. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug Alcohol Depend 1995; 38: 213-319
81. Cornish JW, Maany I, Fudala PJ, Neal S, Poole SA, Volpicelli P, O'Brien CP. Carbamazepine treatment for cocaine dependence. Drug and Alcohol Dependence 1995; 38: 221-227
82. Halikas JA, Crosby RD, Pearson VL, Graves NM. A randomized double-blind study of carbamazepine in the treatment of cocaine abuse. Clinical Pharmacology and Therapeutics 1997; 62 (1): 89-105
83. Hatsukami D, Keenan R, Halikas J, Pentel PR, Brauer LH. Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users. Psychopharmacology 1991; 104: 120-124
84. Alim TN, Rosse RB, Vocci FJ, Linquist T, Deutsch SI. Diethylpropion pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence: a test of the cocaine-agonist hypothesis. Clinical Neuropharmacology 1995; 18 (2): 183-195
85. Ritz MC, Kuhar MJ. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 1989; 248 (3): 1010-1017
86. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZW, Hill E, Cassin BJ, Watson SJ, Cook EH. Cocaine, ethanol and genotype effects on human midbrain serotonin transporter binding sites and mRNA-levels. Am J Psychiatry 1998; 155 (2): 207-213
87. Walsh SL, Preston KL, Sullivan JT, Fromme R, Bigelow GE. Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol 1994; 14 (6): 396-407
88. Covi L, Hess JM, Kreiter NA, Haertzen CA. Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 1995; 21 (3): 327-344
89. Batki SL, Washburn AM, Delucchi K, Jones RT. A controlled trial of fluoxetine in crack cocaine dependence. Drug and Alcohol Dependence 1996; 41: 137-142
90. Giannini AJ, Loiselle RH, Graham BH, Folts DJ. Behavioral response to buspirone in cocaine and phencyclidine withdrawal. J Subst Abuse Treatment 1993; 10: 523-527
91. Golwyn DH. Cocaine abuse treated with phenelzine. Int J Addict 1988; 23: 897-905
92. Gerrits MA, van-Ree JM. Assessment of motivational aspects involved in initiation of cocaine and heroin self-administration in rats. Pharmacol Biochem Behav 1995; 52 (1): 35-42
93. Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR. Effects of naltrexone on cue-elicited craving for alcohol and cocaine. Drug Alcohol Depend 1997; 49 (1): 9-16
94. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 1992; 49 (11): 881-887
95. O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA 1998; 279 (3): 229-234
96. McCance-Katz EF, Kosten TR, Jatlow P. Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. Biol Psychiatry 1998; 43: 540-543
97. Carroll KM, Ziedonis D, O'Malley S, McCance-Katz EF, Gordon L, Rounsaville B. Pharmacologic interventions for abusers of alcohol and cocaine: a pilot study of disulfiram versus naltrexone. J Drug Addiction 1993; 2: 77-79
98. Van Etten ML, Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F. Disulfiram therapy in patients abusing cocaine and alcohol. NIDA Res Monogr 1994; 141: 443
99. Carroll KM, Nich C, Ball SA, McCance-Katz EF, Rounsaville BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998; 93 (5): 713-727
100. Crosby RD, Pearson VL, Eller C, Winegarden T, Graves NL. Phenytoin in the treatment of cocaine abuse: a double-blind study. Clin Pharmacol Ther 1996; 59 (4): 458-468
101. Markowitz JS, Finkenbine R, Myrick H, King L, Carson WH. Gabapentin abuse in a cocaine user: implications for treatment? [letter]. J Clin Psychopharmacol 1997; 17 (5): 423-424
102. Margolin A, Kosten T, Tetrakis I, Avants SK, Kosten T. Bupropion reduces cocaine abuse in methadone-maintained patients. Arch Gen Psychiatry 1991; 48: 87
103. Margolin A, Avants SK, Chang P, Birch S, Kosten TR. A single-blind investigation of four auricular needle puncture configurations. Am J Chin Med 1995; 23 (2): 105-114
104. McKay JR, McLellan AT, Alterman AI. An evaluation of the Cleveland criteria for inpatient treatment of substance abuse. Am J Psychiatry 1992; 149: 1212-1218
105. Alterman AI, O'Brian CP, McLellan AT, August DS, Snider EC, Droba M, Cornish JW, Hall CP, Raphaelson AH, Schrade FX. Effectiveness and cost of inpatients versus day hospital cocaine rehabilitation. Journal of Nervous and Mental Disease 1994; 182 (3): 157-163
106. Budde D, Rounsaville B, Byant K. Inpatient and outpatient cocaine abuser: clinical comparisons at intake and one-year follow-up. J Subst Abuse Treat 1992; 9: 337-342
107. Schmitz JM, Oswald LM, Jacks SD, Rustin T, Rhoades HM, Grabowski J. Relapse prevention treatment for cocaine dependence: group vs. individual format. Addictive Behav 1997; 22 (3): 405-418
108. Weinstein SP, Gottheil E, Sterling RC. Cocaine users in medical practice: A five-year follow-up. Am J Drug Alcohol Abuse 1997; 18/2: 157-166
109. McKay JR, Alterman AI, Cacciola JS, Rutherford MJ, O'Brian CP, Koppenhaver J. Group counseling versus individualized relapse prevention after following intensive outpatient treatment for cocaine dependence: initial results. J Cons Clin Psychology 1997; 5: 778-788
110. Carroll KM, Rounsaville BJ, Gawin F. A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am J Drug Alcohol Abuse 1991; 17: 229-247
111. Higgins ST, Budney AJ, Bickel WK. Applying behavioral concepts and principles to the treatment of cocaine dependence. Drug and Alcohol Dependence 1994; 34: 87-97
112. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger GJ. Achieving cocaine abstinence with a behavioral approach. Am J Psychiatry 1993; 150: 763-769
113. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocain dependence. Arch Gen Psychiatry 1994; 51: 568-576
114. Getter H, Litt MD, Kadden RM, Cooney NL. Measuring treatment process in coping skills and international group therapies for alcoholism. Int J Group Psychotherapy 1992; 42: 419-429
115. Wells EA, Peterson PS, Gainey RR, Hawkins JD, Catalano RF. Outpatient treatment for cocaine abuse: a controlled comparison of relapse preventions and twelve-step approaches. Am J Drug AIc Abuse 1994; 20: 1-17
116. Stephens RS, Roffman RA, Simpson E. Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychology 1994; 62: 92-99
117. Rawson RA, Obert JL, McCann MJ, Ling W. Psychological approaches for the treatment of cocaine dependence - a neurobehavioural approach. J Addictive Dis 1991; 1 (2): 97-119
118. O'Brien CP, Chilldress AR, McLellan T, Ehrman R. Integrating systemic cue exposure with standard treatment in recovering drug dependent patients. Addict Behav 1990; 15: 355-365
119. Schiffer R. Psychotherapy of nine successfully treated cocaine abusers: techniques and dynamics. J Subst Abuse Treat 1988; 5 (3): 131-137
120. Khantzian EJ, Halliday KS, McAuliffe WE. Addiction and the vulnerable self: Modified dynamic group therapy for substance abusers. New York: Guilford Press, 1990: 81-91
121. Galanter M, Egelko S, DeLeon G, Rohrs C. A general hospital day program combining peer-led and professional treatment of cocaine abusers. Hosp Community Psychiatry 1993: 44: 644-649
122. McKay JR, Alterman AI, McLellan AT, Snider E. Treatment goals, continuity of care and outcome in a day hospital substance abuse rehabilitation program. Am J Psychiatry 1994; 151: 254-259
123. Weiss RD, Marinez-Raga J, Griffin ML, Greenfiled SF, Hufford C. Gender differences in cocaine dependent patients: a 6-month follow-up study. Drug Alcohol Depend 1997; 44: 35-40
124. Kosten TA, Gawin FH, Kosten TR, Rounsaville BJ. Gender differences in cocaine use and treatment response. J Subst Abuse Treat 1993; 10 (1): 63-66
125. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken LS, Muenz LR, Thase ME, Weiss RD, Gastfriend DR, Woody GE, Barber JP, Butler SF, Daley D, Salloum I, Bishop S, Najavits LM, Lis J, Mercer D, Griffin ML, Moras K, Beck AT. The National institute on drug abuse collaborative cocaine treatment study. Psychosocial treatments for cocaine dependence. Arch Gen Psychiatry 1999; 56: 493-502
126. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Bisighini RM, Gawin FH. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994; 51: 177-187
127. Hall SM, Tunis S, Triffleman E, Banys P, Clark HW, Tusel D, Stewart P, Presti D. Continuity of care and desipramine in primary cocaine abusers. J Nerv Ment Dis 1994; 182 (10): 570-575
128. Carroll KM, Nich C, Ball SA, McCance E, Rounsaville BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998; 93 (5): 713-727
129. Smith MO. Acupuncture treatment for crack: clinical survey of 1500 Patients treated. Am J Acupuncture 1988; 16: 241-247
130. Margolin A, Kosten TR, Avants SK, Wilkins J, Ling W, Beckson M, Arndt IO, Cornish J, Ascher JA, Li SH, Bridge P. A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend 1995; 40 (2): 125-131
131. Avants SK, Margolin A, Chang P, Kosten TR, Birch S. Acupuncture for the treatment of cocaine addiction. Investigation of a needle puncture control. J Subst Abuse Treat 1995; 12 (3): 195-205
132. Frawley PJ, Smith JW. Chemical aversion therapy in the treatment of cocaine dependence as part of a multimodal treatment program: treatment outcome. J Subst Abuse Treat 1990; 7: 21-29
133. Landry DW, Zhao K, Yang GX, Glickman M, Georgiadis TM. Antibody-catalyzed degradation of cocaine. Science 1993; 259: 1899-1901
134. Meyer RE. New Pharmacotherapies for cocaine dependence. Revisited Arch Gen Psychiatry 1992; 49: 900-904